BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 11, 2005
View Archived Issues
PIPE To Give La Jolla $66M For Additional Riquent Study
A stock and warrant sale is providing a much needed shot in the arm to La Jolla Pharmaceutical Co., which is raising $66 million in gross proceeds to hopefully get Riquent (abetimus) across the finish line. (BioWorld Today)
Read More
Somaxon IPO Bid Seeking $86.25M For Silenor, More
Read More
Welsh Bioscience On The Map And Producing Growing Interest
Read More
Vasogen Adds $40M Through Notes Sale For Celacade Work
Read More
Holiday notice
Read More
Other News To Note
Read More